Critical Update for the Treatment of Anemia by using Advanced Genome Editing Crispr Cas Technology
Ghulam Akbar1*, Ali Ahmad2, Neha Arooj1, Muhammad Anjum Zia1, Aamna Rafique1, Sania Riasat1, Mohsin Raza1, Mahpara Qamar1, Shahneela Nusrat1 and Shakila Hanif1
Figure 1:
General mechanism of CRISPR Cas9 technique of genome editing (Akbar et al., 2020).
Figure 2:
Red blood cells from patient with sickle cell disease. The cells were differentiated from bone marrow with unedited and edited hematopoietic stem cells, and the red arrows show the sickled cells (Posted on April 2nd, 2019 by Dr. Francis Collins on NIH Director’s Blog and Credit: Wu et al. Nature Medicine. March 25, 2019).
December 2020
Vol. 6, Iss. 2, Pages 77-235
